BamSEC and AlphaSense Join Forces
Learn More

Chernett Jorey – Underwriting Agreements

Underwriting Agreements Filter

EX-1
from SCHEDULE 13D/A 1 page Transactions in the Securities of the Issuer Since the Filing of Amendment No. 3 to the Schedule 13d Shares of Common Stock Purchased/(Sold) Price Per Share ($)1 Date of Purchase / Sale 14,000 3.16 8/14/2026
12/34/56
EX-1
from SCHEDULE 13D 1 page Exhibit 1 – Letter to Issuer Jorey Chernett, Owner of More Than 5.5% of Outstanding Shares of CVRX, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer Delivers Letter to the CVRx Board Highlighting Significant Value Proposition of Barostim to a Large Medical Device Company With Established Infrastructure to Capitalize on the Product’s Market Position
12/34/56
EX-1
from SCHEDULE 13D/A 1 page Transactions in the Securities of the Issuer Since the Filing of Amendment No. 2 to the Schedule 13d Shares of Common Stock Purchased/(Sold) Price Per Share ($)1 Date of Purchase / Sale 35,000 1.78 7/14/2026
12/34/56
EX-1
from SCHEDULE 13D 3 pages Exhibit 1 – Letter to Issuer
12/34/56
EX-1
from SCHEDULE 13D/A 1 page Transactions in the Securities of the Issuer Since the Filing of Amendment No. 2 to the Schedule 13d Shares of Common Stock Purchased/(Sold) Price Per Share ($)1 Date of Purchase / Sale 100,000 1.58 4/20/2026 100,000 1.51 4/21/2026 475,000 1.34 5/12/2026 100,000 1.17 5/19/2026
12/34/56
EX-1
from SCHEDULE 13D/A Underwriting agreement
12/34/56
EX-1
from SCHEDULE 13D 1 page Transactions in the Securities of the Issuer in the Past 60 Days Shares of Common Stock Purchased/(Sold) Price Per Share ($)1 Date of Purchase / Sale
12/34/56